RxDoctor Payments Data

Cassandra Schmidt, PA

Physician Assistant · Saint Louis, MONPI 1881085256

Payments from drug & device makers

$1,113in general payments, 2019–2025

Across 45 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$192
  • Exact Sciences$178
  • Lilly USA, LLC$171
  • AbbVie$139
  • Gilead$107
  • Novo Nordisk$59
  • plus $266 from 10 others

What the payments were for

  • Food & beverage$1,113100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,113 in reported general payments places this provider in the 75th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$14,700
Medicare patients
99
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin91$67,503
OzempicSemaglutide28$44,522
TrulicityDulaglutide42$43,424
FarxigaDapagliflozin Propanediol37$31,056
MounjaroTirzepatide13$15,965
SymbicortBudesonide/Formoterol Fumarate44$13,624
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,213
Albuterol Sulfate HfaAlbuterol Sulfate95$2,871
Gabapentin97$2,133
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$2,072
Atorvastatin Calcium169$1,313
Wixela InhubFluticasone Propion/Salmeterol14$1,131
Amlodipine Besylate235$893
Omeprazole42$867
Pantoprazole Sodium41$739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$171$59,38955 claims
AstraZenecaFarxiga, Symbicort$33$44,68081 claims
Novo NordiskOzempic$59$44,52228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →